|
Volumn 27, Issue 5, 2007, Pages 305-312
|
Clinical significance of quantitation of WT1 gene expression for minimal residual disease monitoring of acute myelogenous leukemia
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
PRAM1 PROTEIN, HUMAN;
SIGNAL TRANSDUCING ADAPTOR PROTEIN;
UNCLASSIFIED DRUG;
WT1 PROTEIN;
ADULT;
AGED;
ARTICLE;
FEMALE;
FOLLOW UP;
GENE EXPRESSION;
GENETICS;
HUMAN;
MALE;
MIDDLE AGED;
MINIMAL RESIDUAL DISEASE;
MORTALITY;
MYELOMONOCYTIC LEUKEMIA;
POLYMERASE CHAIN REACTION;
PROGNOSIS;
SURVIVAL;
TUMOR SUPPRESSOR GENE;
ADAPTOR PROTEINS, SIGNAL TRANSDUCING;
ADULT;
AGED;
AGED, 80 AND OVER;
FEMALE;
FOLLOW-UP STUDIES;
GENE EXPRESSION;
GENES, WILMS TUMOR;
HUMANS;
LEUKEMIA, MYELOMONOCYTIC, ACUTE;
MALE;
MIDDLE AGED;
NEOPLASM, RESIDUAL;
POLYMERASE CHAIN REACTION;
PROGNOSIS;
SURVIVAL ANALYSIS;
WT1 PROTEINS;
|
EID: 56149101177
PISSN: 15986535
EISSN: None
Source Type: Journal
DOI: 10.3343/kjlm.2007.27.5.305 Document Type: Article |
Times cited : (4)
|
References (0)
|